Abstract:Backgroud High comorbidity rates have been reported in patients with atherosclerosis and osteoporosis, posing a serious risk to the health and well-being of elderly patients. To improve and update clinical practice regarding the joint treatment of these two diseases, the common mechanisms of atherosclerosis and osteoporosis need to be clarified. MicroRNAs (miRNAs), are importance molecules in the pathogenesis of human diseases, including in cardiovascular and orthopedic fields. They have garnered interest as potential targets for novel therapeutic strategies. However, the key miRNAs involved in atherosclerosis and osteoporosis and their precise regulation mechanisms remain unknown. Paeonol (Pae), an active ingredient in Cortex Moutan, has shown promising results in improving both lipid and bone metabolic abnormalities. However, it is uncertain whether this agent can exert a cotherapeutic effect on atherosclerosis and osteoporosis. Objective This study aimed to screen important shared miRNAs in atherosclerotic and osteoporotic complications, and explore the mechanism of the protective effects of Pae against atherosclerosis and osteoporosis in high-fat diet (HFD)-fed ApoE −/− mice. Methods An experimental atherosclerosis and osteoporosis model was established in 40-week-old HFD ApoE −/- mice. Various techniques such as Oil Red O staining, HE staining and micro-CT were used to confirm the co-occurrence of these two diseases and efficacy of Pae in addition to the associated biochemical changes. Bioinformatics was used to screen key miRNAs in the atherosclerosis and osteoporosis model, and gene involvement was assessed through serum analyses, qRT-PCR, and western blot. To investigate the effect of Pae on the modulation of the miR let-7g/HMGA2/CEBPβ pathway, Raw 264.7 cells were cocultured with bone marrow mesenchymal stem cells (BMSCs) and treated with an miR let-7g mimic/inhibitor. Results miR let-7g identified using bioinformatics was assessed to evaluate its participation in atherosclerosis-osteoporosis. Experimental analysis showed reduced miR let-7g levels in the atherosclerosis-osteoporosis mice model. Moreover, miR let-7g was required for BMSC - Raw 264.7 cell crosstalk, thereby promoting foam cell formation and adipocyte differentiation. Treatment with Pae significantly reduced plaque accumulation and foam cell number in the aorta while increasing bone density and improving trabecular bone microarchitecture in HFD ApoE −/- mice. Pae also increased the level of miR let-7g in the bloodstream of model mice. In vitro studies, Pae enhanced miR let-7g expression in BMSCs, thereby suppressing the HMGA2/CEBPβ pathway to prevent the formation of foam cells and differentiation of adipocytes induced by oxidized low-density lipoprotein (ox-LDL). Conclusion The study results suggested that miR let-7g participates in atherosclerosis -osteoporosis regulation and that Pae acts as a potential therapeutic agent for preventing atherosclerosis-osteoporosis through regulatory effects on the miR let-7g/HMGA2/CEBPβ pathway to hinder foam cell formation and adipocyte differentiation.

The effects and mechanism of paeoniflorin in promoting osteogenic differentiation of MC3T3-E1

Paeoniflorin Regulates Osteoclastogenesis and Osteoblastogenesis Via Manipulating NF-κB Signaling Pathway Both in Vitro and in Vivo

Beneficial Effects of Paeoniflorin on Osteoporosis Induced by High-Carbohydrate, High-Fat Diet-Associated Hyperlipidemia in Vivo

Paeoniflorin Inhibits IL-1β-induced MMP Secretion Via the NF-κB Pathway in Chondrocytes.

M13, an Anthraquinone Compound Isolated from Morinda Officinalis Promotes the Osteogenic Differentiation of MSCs by Targeting Wnt/β-catenin Signaling.

Puerarin Inhibits TRPM3/miR-204 to Promote MC3T3-E1 Cells Proliferation, Differentiation and Mineralization

Paeoniflorin Inhibits Receptor Activator for Nuclear Factor Κb (RANK) Ligand-Induced Osteoclast Differentiation in Vitro and Particle-Induced Osteolysis in Vivo.

The Protective Effect of Piperine on Ovariectomy Induced Bone Loss in Female Mice and Its Enhancement Effect of Osteogenic Differentiation Via Wnt/β-catenin Signaling Pathway

Paeoniflorin Inhibits IL-1β-induced Chondrocyte Apoptosis by Regulating the Bax/Bcl-2/caspase-3 Signaling Pathway

Effects of Paeonol on the Function of Bone Marrow-Derived Macrophage Fromporphyromonas Gingivalis-Induced Mice

The Proliferation, Differentiation, and Mineralization Effects of Puerarin on Osteoblasts in Vitro

Effect of Puerarin on Osteogenic Differentiation in vitro and on New Bone Formation in vivo

Protective effects of paeoniflorin and albiflorin on chemotherapy-induced myelosuppression in mice

Coordinate Regulatory Osteogenesis Effects of Icariin, Timosaponin B II and Ferulic Acid from Traditional Chinese Medicine Formulas on UMR-106 Osteoblastic Cells and Osteoblasts in Neonatal Rat Calvaria Cultures

Pectolinarigenin ameliorates osteoporosis via enhancing Wnt signaling cascade in PPARβ-dependent manner

MicroRNA let-7g links foam cell formation and adipogenic differentiation: a key regulator of Paeonol treating atherosclerosis-osteoporosis

Promoting Effect of Pinostrobin on the Proliferation, Differentiation, and Mineralization of Murine Pre-osteoblastic MC3T3-E1 Cells

Stimulative effects of Polygonum amplexicaule var. sinense on osteoblastic MC3T3-E1 cells.

Paeonol impacts ovarian cancer cell proliferation, migration, invasion and apoptosis via modulating the transforming growth factor beta/smad3 signaling pathway

Molecular Mechanism of Paeoniflorin Regulating Transforming Growth Factor-Β in Inhibiting the Epithelial-Mesenchymal Transition of Glioma U87 Cells

Puerarin Stimulates Osteoblasts Differentiation and Bone Formation Through Estrogen Receptor, P38 MAPK, and Wnt/β-catenin Pathways.